Overath, Germany

Klaus Witthohn

USPTO Granted Patents = 9 


 

Average Co-Inventor Count = 3.2

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 1995-2019

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Klaus Witthohn: Innovator in Antiviral Treatments

Introduction

Klaus Witthohn is a distinguished inventor based in Overath, Germany, known for his significant contributions to the field of antiviral agents. With a total of nine patents to his name, he has focused on developing innovative treatments that combat various viral infections and cancers.

Latest Patents

Witthohn's most recent patents include groundbreaking work on antiviral agents that utilize recombinant mistletoe lectins. His innovations offer promising solutions for treating viral infections such as Herpes simplex, adenovirus, poliovirus, and poxvirus. One notable patent describes an antiviral agent that combines these lectins with pharmaceutical compositions aimed at addressing skin warts and malignant tumors, including cervical, penile, and vulvar cancers.

Moreover, he has developed a drug comprising recombinant mistletoe lectins explicitly intended for the treatment of malignant melanoma, particularly in advanced stages. The drug is designed for tailored use in specific patient populations and may improve outcomes for those who have not responded well to standard therapies.

Career Highlights

During his career, Klaus Witthohn has worked with several notable companies in the biopharmaceutical sector, including Madaus AG and Cytavis Biopharma GmbH. His work has had a significant impact on the development of antiviral and anticancer therapies, emphasizing his dedication to advancing medical science.

Collaborations

Throughout his professional journey, Witthohn has collaborated with esteemed colleagues such as Alfons Carcasona and Wolf Grimminger. These partnerships have been instrumental in evolving his ideas and bringing innovative treatments to fruition.

Conclusion

Klaus Witthohn's pioneering work in antiviral and anticancer research highlights his role as a leading inventor in the field. With nine patents to his name, his innovative approaches to treatment could potentially change the landscape of how viral infections and malignant tumors are managed in clinical settings. His commitment to research and collaboration continues to drive advancements in medical therapies, benefiting patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…